DK0542609T3 - 3-sulfonylamino-2- (1H) -quinolinone and 7-aza derivatives thereof as excitatory amino acid antagonists - Google Patents

3-sulfonylamino-2- (1H) -quinolinone and 7-aza derivatives thereof as excitatory amino acid antagonists

Info

Publication number
DK0542609T3
DK0542609T3 DK92403014.1T DK92403014T DK0542609T3 DK 0542609 T3 DK0542609 T3 DK 0542609T3 DK 92403014 T DK92403014 T DK 92403014T DK 0542609 T3 DK0542609 T3 DK 0542609T3
Authority
DK
Denmark
Prior art keywords
branched
linear
trihalomethyl
unsubstituted
substituted
Prior art date
Application number
DK92403014.1T
Other languages
Danish (da)
Inventor
Jean Lepagnol
Alex Cordi
Patrice Desos
John Randle
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0542609T3 publication Critical patent/DK0542609T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Abstract

Compounds of formula (I): <IMAGE> in which: X, Y, Z - which are identical or different, represent a hydrogen atom, a halogen atom or a nitro, cyano, azido, trihalomethyl, linear or branched (C1-C6)alkyl, linear or branched (C1-C6)alkoxy, or amino (unsubstituted or substituted by a linear or branched (C1-C6)acyl group) group, - or else, when they are situated on two adjacent carbons, form, with the carbon atoms to which they are attached, a phenyl ring or a 5- or 6-membered heterocycle containing from 1 to 3 hetero atoms, preferably a 1,2,5-oxadiazole ring, R represents a linear or branched (C1-C6)alkyl, trihalomethyl, phenyl (unsubstituted or substituted by one or a number of halogen atoms or linear or branched (C1-C6)alkyl, trihalomethyl or linear or branched (C1-C6)alkoxy groups), 2-thienyl (unsubstituted or substituted by a halogen atom), naphthyl or styryl group, A represents a CH radical or a nitrogen atom. Medicaments.
DK92403014.1T 1991-11-14 1992-11-09 3-sulfonylamino-2- (1H) -quinolinone and 7-aza derivatives thereof as excitatory amino acid antagonists DK0542609T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113977A FR2683818B1 (en) 1991-11-14 1991-11-14 NOVEL 3-SULFONYLAMINO-2- (1H) -QUINOLEINONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Publications (1)

Publication Number Publication Date
DK0542609T3 true DK0542609T3 (en) 1995-03-20

Family

ID=9418879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92403014.1T DK0542609T3 (en) 1991-11-14 1992-11-09 3-sulfonylamino-2- (1H) -quinolinone and 7-aza derivatives thereof as excitatory amino acid antagonists

Country Status (11)

Country Link
EP (1) EP0542609B1 (en)
JP (1) JPH06102650B2 (en)
AT (1) ATE111082T1 (en)
AU (1) AU651255B2 (en)
CA (1) CA2082856A1 (en)
DE (1) DE69200394T2 (en)
DK (1) DK0542609T3 (en)
ES (1) ES2064156T3 (en)
FR (1) FR2683818B1 (en)
NZ (1) NZ245127A (en)
ZA (1) ZA928727B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2709489B1 (en) * 1993-08-31 1995-10-20 Adir New derivatives of 2- (1H) -quinolineone, their preparation process and the pharmaceutical compositions containing them.
FR2750988B1 (en) * 1996-07-11 1998-09-18 Adir NOVEL 2- (1H) -QUINOLEINONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US20020065296A1 (en) 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
WO2000041698A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
EP1690853B1 (en) 1999-01-13 2010-03-10 Bayer HealthCare LLC Use of omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
CA2378298A1 (en) 1999-08-27 2001-03-08 Lawrence G. Hamann 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators
PL353792A1 (en) * 1999-08-27 2003-12-01 Ligand Pharmaceuticals Incorporatedligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
CA2383565A1 (en) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
FR2805260A1 (en) * 2000-02-18 2001-08-24 Adir NOVEL 6-SULFAMOYL-3-QUINOLINYL PHOSPHONIC ACID DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2805261A1 (en) * 2000-02-18 2001-08-24 Adir NOVEL 6-AMINO OR 6-HYDRAZINOSULFONYL-3- QUINOLINYL PHOSPHONIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2805262A1 (en) * 2000-02-18 2001-08-24 Adir NOVEL PHYPHONIC ARYL OR HETEROARYL QUINOLINYL ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TWI298068B (en) 2000-06-21 2008-06-21 Dainippon Sumitomo Pharma Co Pharmaceutical composition for schizophrenia
DE602004007382T2 (en) 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven DIARYL UREAS FOR PDGFR MEDIATED DISEASES
CA2536349A1 (en) 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
WO2007053574A2 (en) 2005-10-31 2007-05-10 Bayer Pharmaceuticals Corporation Combinations comprising sorafenib and interferon for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066145A (en) * 1962-02-07 1962-11-27 American Home Prod 3-amino-6-chloro-4-phenyl-2(1h)-quinolone
EP0386839B1 (en) * 1989-03-08 1997-01-15 Merck Sharp & Dohme Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
GB9004288D0 (en) * 1990-02-26 1990-04-18 Almirall Lab New 4(1h)quinoline derivatives

Also Published As

Publication number Publication date
NZ245127A (en) 1994-07-26
EP0542609A1 (en) 1993-05-19
DE69200394D1 (en) 1994-10-13
ES2064156T3 (en) 1995-01-16
EP0542609B1 (en) 1994-09-07
AU651255B2 (en) 1994-07-14
ZA928727B (en) 1993-05-10
CA2082856A1 (en) 1993-05-15
FR2683818A1 (en) 1993-05-21
ATE111082T1 (en) 1994-09-15
FR2683818B1 (en) 1993-12-31
JPH06102650B2 (en) 1994-12-14
DE69200394T2 (en) 1995-04-27
AU2835192A (en) 1993-05-20
JPH05221997A (en) 1993-08-31

Similar Documents

Publication Publication Date Title
DK0542609T3 (en) 3-sulfonylamino-2- (1H) -quinolinone and 7-aza derivatives thereof as excitatory amino acid antagonists
ATE186724T1 (en) SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES
NO179142C (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
DE3888756D1 (en) Carbamoylpyrrolidone derivatives, their use and preparation.
DE68906183T2 (en) 2&#39;-DESOXY-5-FLUORURIDINE DERIVATIVES.
FR2398718A1 (en) NEW PRIMARY AMINES USEFUL FOR THE PREPARATION OF AMINOALKYL BENZENE DERIVATIVES
ATE32894T1 (en) THIOMETHYLPYRIDIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
CO4650030A1 (en) DERIVATIVES OF N- (BENZOTIAZOL-2-IL) PIPERIDINE-1-ETHANAMINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL PRODUCT CONTAINING THEM
ATE69605T1 (en) AZOLYLPROPENYL AND AZOLYLMETHYLOXIRANE DERIVATIVES AND FUNGICIDES CONTAINING THEM.
DK0640612T3 (en) New derivatives of 2- (1H) -quinolinone, process for their preparation and pharmaceutical compositions containing
DK508484A (en) N-SUBSTITUTED ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
ES468939A1 (en) O-Alkylated oximes and pharmaceutical composition thereof
DK0538477T3 (en) Novel cyclic aminophenylacetic acid derivatives, their preparation and immunoreacton modulator containing these as active ingredient
AR241021A2 (en) Thienopyridine derivatives and anti-thrombotic compositions containing the same
FI933468A (en) Tetrahydronaphthalene derivatives, framstaellning av dessa och therapeutisk anvaendning av dessa
SE8200320L (en) NEW DERIVATIVES OF SPIRO-1 ISOBENSOFURANES AND SPIRO-1 ISOBENSOTIOFENES, DERAS PREPARATIONS AND THERAPEUTIC USE